Literature DB >> 9367778

In vitro structure-function analysis of the beta-strand 326-333 of human p53.

P Chène1, P Mittl, M Grütter.   

Abstract

The beta-strand 326-333 is a key structural element in the formation of p53 tetramers. To investigate the contribution of its amino acid residues, an alanine scan was performed. The oligomerisation and DNA-binding properties of the mutant proteins were compared with those of wild-type proteins in vitro and analysed on the basis of the crystal structure of the p53 tetramerisation domain at 1.5 A resolution. Two categories of mutant proteins were identified. Phe328Ala, Leu330Ala and Ile332Ala mutant proteins are inactive for DNA binding and oligomerisation, while the Glu326Ala, Tyr327Ala, Thr329Ala, Gln331Ala and Arg333Ala mutant proteins have properties similar to those of wild-type proteins. These results suggest that single mutations within the p53 tetramerisation domain destabilise the structure of the whole protein, inhibiting its DNA-binding activity. Furthermore, the mutation of leucine 330 to alanine within the tetramerisation domain of the Arg175His protein abolishes the dominant negative effect of this mutant. This shows that the beta-strand 326-333 is a key structural element that mediates the dominant negative effect of p53 mutants. Copyright 1997 Academic Press Limited

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367778     DOI: 10.1006/jmbi.1997.1360

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Four p(53)s in a pod.

Authors:  Seth Chitayat; Cheryl H Arrowsmith
Journal:  Nat Struct Mol Biol       Date:  2010-04       Impact factor: 15.369

2.  Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain.

Authors:  M G Mateu; A R Fersht
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

3.  Tetramerization-defects of p53 result in aberrant ubiquitylation and transcriptional activity.

Authors:  Valérie Lang; Chiara Pallara; Amaia Zabala; Sofia Lobato-Gil; Fernando Lopitz-Otsoa; Rosa Farrás; Roland Hjerpe; Monica Torres-Ramos; Lorea Zabaleta; Christine Blattner; Ronald T Hay; Rosa Barrio; Arkaitz Carracedo; Juan Fernandez-Recio; Manuel S Rodríguez; Fabienne Aillet
Journal:  Mol Oncol       Date:  2014-04-13       Impact factor: 6.603

Review 4.  The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.

Authors:  Callum Hall; Patricia A J Muller
Journal:  Int J Mol Sci       Date:  2019-12-07       Impact factor: 5.923

5.  Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.

Authors:  Jennifer J Jordan; Daniel Menendez; Alberto Inga; Maher Noureddine; Maher Nourredine; Douglas A Bell; Douglas Bell; Michael A Resnick
Journal:  PLoS Genet       Date:  2008-06-27       Impact factor: 5.917

6.  A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect.

Authors:  Yunguang Sun; Carey Jeanne Myers; Adam Paul Dicker; Bo Lu
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

Review 7.  p53 tetramerization: at the center of the dominant-negative effect of mutant p53.

Authors:  Jovanka Gencel-Augusto; Guillermina Lozano
Journal:  Genes Dev       Date:  2020-09-01       Impact factor: 11.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.